Liver X receptor modulators: a review of recently patented compounds (2009 – 2012)

Author： Loren Jon   Huang Zhihong   Laffitte Bryan A   Molteni Valentina  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.23, Iss.10, 2013-10, pp. : 1317-1335

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Liver X receptor modulators: a review of recently patented compounds (2007 – 2009)

By Li Xiaolin   Yeh Vince   Molteni Valentina  

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 4, 2010-04 ,pp. : 535-562

Informa Healthcare

Access to resources Recommend Favorite

Orexin receptor antagonists: a review of promising compounds patented since 2006

By Coleman Paul J   Renger John J  

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 3, 2010-03 ,pp. : 307-324

Informa Healthcare

Access to resources Recommend Favorite

Patented TGR5 modulators: a review (2006 – present)

By Gioiello Antimo   Rosatelli Emiliano   Nuti Roberto   Macchiarulo Antonio   Pellicciari Roberto  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 12, 2012-12 ,pp. : 1399-1414

Informa Healthcare

Access to resources Recommend Favorite

Selective cannabinoid receptor 2 modulators: a patent review 2009 – present

By Riether Doris  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 5, 2012-05 ,pp. : 495-510

Informa Healthcare

Access to resources Recommend Favorite

Novel prostaglandin receptor modulators – Part II: EP receptor modulators; a patent review (2002 – 2012)

By Flesch Daniel   Merk Daniel   Lamers Christina   Schubert-Zsilavecz Manfred  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 2, 2013-02 ,pp. : 233-267

Informa Healthcare

Access to resources Recommend Favorite